Literature DB >> 8412022

Recent developments in Menkes disease.

H Kodama1.   

Abstract

Recent studies on Menkes disease are reviewed, focusing especially on copper transport in the cells. A large amount of copper accumulated in the organelle-free cytoplasm, whereas mitochondria were in a state of copper deficiency, indicating that Menkes mutation probably affects copper transport from the cytosol to the organelles in the cells. Microscopic observation of the brain of the macular mouse showed that copper accumulates in the blood vessels. Observation of the brain tissue of the macular mouse after intraventricular administration of copper revealed that copper accumulates in the glia as well as the blood vessels. Copper accumulation was also observed in cultured astrocytes, a type of glial cell, indicating that the affected astrocytes accumulate blood-borne copper and release little of it in the patients with Menkes disease. Thus the effective treatment of Menkes disease could possibly be to release trapped copper from the blood vessels and glia into the neurons.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8412022     DOI: 10.1007/bf00711911

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  28 in total

1.  MR of progressive neurodegenerative change in treated Menkes' kinky hair disease.

Authors:  D E Johnsen; L Coleman; L Poe
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

2.  Multipoint linkage analysis in Menkes disease.

Authors:  T Tønnesen; A Petterson; T A Kruse; A M Gerdes; N Horn
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

3.  First-trimester diagnosis of Menkes disease: intermediate copper values in chorionic villi from three affected male fetuses.

Authors:  T Tønnesen; A M Gerdes; E Damsgaard; P Miny; W Holzgreve; F Søndergaard; N Horn
Journal:  Prenat Diagn       Date:  1989-03       Impact factor: 3.050

4.  Isolation of a candidate gene for Menkes disease that encodes a potential heavy metal binding protein.

Authors:  J Chelly; Z Tümer; T Tønnesen; A Petterson; Y Ishikawa-Brush; N Tommerup; N Horn; A P Monaco
Journal:  Nat Genet       Date:  1993-01       Impact factor: 38.330

5.  Copper deficiency in the mitochondria of cultured skin fibroblasts from patients with Menkes syndrome.

Authors:  H Kodama; I Okabe; M Yanagisawa; Y Kodama
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

6.  Correction of cerebrospinal fluid copper in Menkes kinky hair disease.

Authors:  P R Kollros; R D Dick; G J Brewer
Journal:  Pediatr Neurol       Date:  1991 Jul-Aug       Impact factor: 3.372

7.  An X-linked disease of the nervous system with disordered copper metabolism and features differing from Menkes disease.

Authors:  R H Haas; A Robinson; K Evans; P T Lascelles; V Dubowitz
Journal:  Neurology       Date:  1981-07       Impact factor: 9.910

8.  Changes of copper level and cytochrome c oxidase activity in the macular mouse with age.

Authors:  Y Meguro; H Kodama; T Abe; S Kobayashi; Y Kodama; M Nishimura
Journal:  Brain Dev       Date:  1991-05       Impact factor: 1.961

9.  Genetic expression of Menkes disease in cultured astrocytes of the macular mouse.

Authors:  H Kodama; Y Meguro; T Abe; M H Rayner; K T Suzuki; S Kobayashi; M Nishimura
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

10.  Electron microscopic study on brain of macular mutant mouse after copper therapy.

Authors:  T Yamano; M Shimada; A Onaga; H Kawasaki; S Iwane; K Ono; M Nishimura
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

View more
  13 in total

1.  Sequence of a Menkes-type Cu-transporting ATPase from rat C6 glioma cells: comparison of the rat protein with other mammalian Cu-transporting ATPases.

Authors:  Y Qian; E Tiffany-Castiglioni; E D Harris
Journal:  Mol Cell Biochem       Date:  1998-04       Impact factor: 3.396

Review 2.  Menkes disease.

Authors:  A Bankier
Journal:  J Med Genet       Date:  1995-03       Impact factor: 6.318

3.  Pituitary adenylyl cyclase-activating peptides and alpha-amidation in olfactory neurogenesis and neuronal survival in vitro.

Authors:  D E Hansel; V May; B A Eipper; G V Ronnett
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

Review 4.  Astrocytes: the missing link in neurologic disease?

Authors:  Chia-Ching John Lin; Benjamin Deneen
Journal:  Semin Pediatr Neurol       Date:  2013-10-16       Impact factor: 1.636

Review 5.  Handling of Copper and Copper Oxide Nanoparticles by Astrocytes.

Authors:  Felix Bulcke; Ralf Dringen
Journal:  Neurochem Res       Date:  2015-08-13       Impact factor: 3.996

6.  Neurodevelopment and brain growth in classic Menkes disease is influenced by age and symptomatology at initiation of copper treatment.

Authors:  Stephen G Kaler
Journal:  J Trace Elem Med Biol       Date:  2014-08-28       Impact factor: 3.849

7.  Effect of copper and diethyldithiocarbamate combination therapy on the macular mouse, an animal model of Menkes disease.

Authors:  H Kodama; E Sato; Y-H Gu; K Shiga; C Fujisawa; T Kozuma
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.750

Review 8.  Inherited copper transport disorders: biochemical mechanisms, diagnosis, and treatment.

Authors:  Hiroko Kodama; Chie Fujisawa; Wattanaporn Bhadhprasit
Journal:  Curr Drug Metab       Date:  2012-03       Impact factor: 3.731

9.  Cerebrospinal Fluid-Directed rAAV9-rsATP7A Plus Subcutaneous Copper Histidinate Advance Survival and Outcomes in a Menkes Disease Mouse Model.

Authors:  Marie Reine Haddad; Eun-Young Choi; Patricia M Zerfas; Ling Yi; Diego Martinelli; Patricia Sullivan; David S Goldstein; Jose A Centeno; Lauren R Brinster; Martina Ralle; Stephen G Kaler
Journal:  Mol Ther Methods Clin Dev       Date:  2018-07-09       Impact factor: 6.698

Review 10.  Mottled Mice and Non-Mammalian Models of Menkes Disease.

Authors:  Małgorzata Lenartowicz; Wojciech Krzeptowski; Paweł Lipiński; Paweł Grzmil; Rafał Starzyński; Olga Pierzchała; Lisbeth Birk Møller
Journal:  Front Mol Neurosci       Date:  2015-12-18       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.